Sun Life Financial CEO Touts 12% EPS Growth, Eyes 20% ROE as U.S. Dental Volatility Looms

1 hour ago 2

MarketBeat

Sat, March 28, 2026 astatine 1:02 PM CDT 8 min read

Sun Life Financial logo

Strong 2025 results: Sun Life reported 12% EPS growth and ROE conscionable implicit 18%, tracking toward its 20% ROE people and exceeding its 10% EPS maturation extremity for the year.
U.S. dental reset: The institution kept its $5 cardinal premium extremity but extended the timeline and shifted the premix from ~75% state/25% commercialized toward a astir 50/50 mix, directing absorption to "optimize" the ~$2.5 cardinal authorities publication alternatively than prioritize growth.
U.S. stop-loss repricing and resilience: After consecutive terms increases (about 14% and 17%) and a Jan. 1 repricing covering two‑thirds of the book, stop-loss claims ran successful the mid‑70s with margins supra people and Sun Life sold a grounds fig of policies for Jan. 1 effectual dates.
Interested successful Sun Life Financial Inc.? Here are 5 stocks we similar better.

Consensus Is These 3 Stocks Are Strong Buys

Sun Life Financial (NYSE:SLF) President and CEO Kevin Strain said the institution delivered a “good twelvemonth successful total” successful 2025, pointing to net per stock maturation of 12% and instrumentality connected equity (ROE) “just implicit 18%,” which helium said tracks toward the company’s 20% ROE target. Speaking successful a year-in-review discussion, Strain besides highlighted enactment changes crossed cardinal concern lines and outlined actions underway to code volatility successful the company’s U.S. dental concern portion expressing assurance successful its U.S. stop-loss operations.

Strain said 2025 “ended connected a beardown note” and described the year’s results arsenic exceeding the company’s 10% EPS maturation target. He besides cited advancement against a five-year capitalist people successful the company’s “SOC” metric, saying it reached “just implicit 240” versus a people of 235.

→ Quiet BNY and Northern Trust Reward Patient Investors

He emphasized respective enactment appointments successful profit-and-loss roles, including:

Manjit Singh starring Asia
Jessica Tan starring Canada
Ted Maloney astatine MFS
Sunny joining SLC
Tom Murphy successful a caller relation overseeing plus management
David Healy starring the United States

Strain said Canada and Asia performed strongly, portion the U.S. concern was “a spot much volatile,” reflecting what helium described arsenic structural changes successful the U.S. healthcare strategy that affected results otherwise crossed quarters.

→ ASML’s $8B Deal: More Than a Purchase, It's a Prophecy

Strain said Sun Life has “reset” goals for its U.S. dental concern aft learning much astir however Medicare and Medicaid dynamics are evolving. He referenced an earlier people discussed connected an capitalist call: $5 cardinal successful premium astatine a 5% margin, oregon $250 cardinal successful profit. While helium reiterated the $5 cardinal premium goal, helium said it “may instrumentality a small spot longer” than primitively expected.

Read Entire Article